Anthropic, the company behind the Claude chatbot, has moved to take its fast-growing artificial intelligence business to Wall Street—pitching AI as a tool that could one day help cure cancer and other major diseases while lifting economies worldwide.
The US technology firm has filed paperwork with the Securities and Exchange Commission as it begins the process of a stock market debut.
Anthropic said it intends to list on the Nasdaq under the ticker symbol “ANT”.
The planned initial public offering is widely viewed as a candidate to become one of the largest and most highly valued flotations globally.
Even so, the company has not yet disclosed how many shares it will offer or the price range it is targeting.
Its prospectus, however, lays out financial results alongside plans for expansion and a detailed overview of opportunities and risks for prospective shareholders.
The prospectus said AI ‘may pose catastrophic or existential risks to humanity’
In the filing, Anthropic describes AI as “one of the most consequential technologies in human history”, arguing it could “improve the quality of human life” across a broad range of areas.
Among the potential benefits, it points to faster scientific breakthroughs and the possibility of “potentially curing diseases that have plagued humanity for millennia, including cancer, Alzheimer’s disease, heart disease, rare genetic diseases and the major infectious diseases”, according to the document.
It also frames AI as a driver of productivity—calling it a “powerful lever for economic growth” that can help workers and businesses through automation.
At the same time, Anthropic devotes substantial space to the downsides associated with advanced AI systems.
The prospectus notes ongoing narratives about “potential adverse societal impacts of AI, including that AI may displace or eliminate jobs, may be misused or otherwise cause harm and may pose catastrophic or existential risks to humanity”.
It singles out cyber threats as a major concern and references an incident in September last year when the company said it “detected and assessed with high confidence that a Chinese state-sponsored hacking group manipulated our Claude Code tool into attempting infiltration into roughly 30 global targets”, including government agencies, with some attempts succeeding.
“We expect that malicious actors, including sophisticated state-sponsored actors, will continue to seek to leverage our models, platform and applications for harmful actions, including by circumventing our safeguards, and their efforts to do so may increase as the capabilities of our technology increase,” the company said.
Meta plans to raise around $95 billion through company stock offerings, to fund further investment into AI
The filing also provides a snapshot of Anthropic’s finances, showing sharply rising revenue alongside continuing losses—an increasingly familiar pattern among high-profile tech companies preparing to go public.
Anthropic reported a net loss of $80.7 billion (€72 billion) in the first half of 2026.
That figure compares with a loss of $13 billion (€11 billion) in the same period a year earlier.
Under its risk disclosures, the company said it has “a history of net losses” and “may not achieve or sustain profitability in the future”.
Revenue reached $16.3 billion (€14 billion) in the first half of 2026, after climbing quickly from $41 million (€36 million) over 2023.
Separately, Meta—the owner of Facebook and Instagram—said it plans to raise around $95 billion (€84 billion) through company stock offerings to support further investment in AI.
Meta said the effort has attracted interest from investors including Nvidia and Broadcom, which it said had indicated an interest in purchasing shares under public offerings.
Meta added that its AI spending is already producing returns and that it is “pursuing new opportunities across personal superintelligence, consumer and business agents, enterprise products and AI glasses”.
For this year, Meta expects capital expenditure to land between $135 billion and $145 billion dollars (€90 – €97 billion).
